The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI) | MicrobiomeTrials← Back to trialsNCT01778569
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
CompletedOBSERVATIONAL
Trial Details
Start: 2013-01-22Est. Completion: 2023-01-06
Enrollment target: 386 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
PrediabetesPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Prediabetes or Diabetes
This study will test whether glucose sensor data can be used to identify the time of day when adults with prediabetes ar…
Lahore, PakistanCompleted Jun 30, 2026
Hermansky-Pudlak Syndrome (HPS)
Hermansky-Pudlak Syndrome (HPS) is an inherited disease which results in decreased pigmentation (oculocutaneous albinism…
Bethesda, United States
Alzheimer Disease and Related Dementias (ADRD)
It is projected that by 2030, one in every five Americans will be of retirement age, and this demographic shift is expec…
London, CanadaEst. completion Mar 2028